#OTILT cefiderocol is an agent that was designed to be structurally similar to siderophores, which are released by bacteria to help take in iron, thus acting as a Trojan horse to get into the bacterial cell @armandbak @BWDionne https://t.co/y4LncUlvvU
RT @jdcarballeira: Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negativ…
RT @jdcarballeira: Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negativ…
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Drugs. https://t.co/DFairBbqIr
6/ Used the Trojan🐎Cefiderocol for some MDR PsA (more than once!) And yes, I check google every time I try to spell it to find where the ‘e’ and ‘o’s are. I still don't know https://t.co/Ygv9EmIlDN https://t.co/Fpi0jbnRto https://t.co/QKKoZhdypt
RT @hannahbrokmeier: (2/11) Let’s explore the newest cephalosporin on the block ➡️ cefiderocol (Fetroja™) - a 1st in class synthetic β-lac…
RT @hannahbrokmeier: (2/11) Let’s explore the newest cephalosporin on the block ➡️ cefiderocol (Fetroja™) - a 1st in class synthetic β-lac…
RT @hannahbrokmeier: (2/11) Let’s explore the newest cephalosporin on the block ➡️ cefiderocol (Fetroja™) - a 1st in class synthetic β-lac…
RT @hannahbrokmeier: (2/11) Let’s explore the newest cephalosporin on the block ➡️ cefiderocol (Fetroja™) - a 1st in class synthetic β-lac…
(2/11) Let’s explore the newest cephalosporin on the block ➡️ cefiderocol (Fetroja™) - a 1st in class synthetic β-lactam = cefepime + ceftazidime + siderophore https://t.co/JeDiJPaBpR https://t.co/7THLqtvXip
@SatyaPatelMD I would say that the important take away is that the bacterial mechanism of iron uptake - siderophores - has resulted in a drug target for (dare I say), the Trojan horse of antibiotics: cefidericol. Hope to never have to use it. https://t.co
RT @MediCasos: Bibliografía: https://t.co/5sx9vTd6wV
RT @MediCasos: Bibliografía: https://t.co/5sx9vTd6wV
RT @MediCasos: Bibliografía: https://t.co/5sx9vTd6wV
RT @MediCasos: Bibliografía: https://t.co/5sx9vTd6wV
Bibliografía: https://t.co/5sx9vTd6wV
@CGentPharm What about possibility of cefiderocol for this patient? Could it be an option in HD with these organisms? @CAG_ID_Doc https://t.co/Abnsi5pB3G and https://t.co/ULIZBr9daD
RT @MayoClinicINFD: 2/ #Cefiderocol Cefiderocol inhibits almost all aerobic GNRs. A unique feature is its activity vs. difficult to treat…
RT @MayoClinicINFD: 1/ #Cefiderocol Is mainly a drug vs. aerobic GNR! - NO activity vs. Gram positives and anaerobes! (Answer to poll - N…
RT @MayoClinicINFD: 1/ #Cefiderocol Is mainly a drug vs. aerobic GNR! - NO activity vs. Gram positives and anaerobes! (Answer to poll - N…
RT @MayoClinicINFD: 2/ #Cefiderocol Cefiderocol inhibits almost all aerobic GNRs. A unique feature is its activity vs. difficult to treat…
2/ #Cefiderocol Cefiderocol inhibits almost all aerobic GNRs. A unique feature is its activity vs. difficult to treat drug resistant P. aeruginosa, A. baumannii, S. maltophilia, B. cepacia Zhanel, G.G. et al. Drugs (2019) 79: 271. https://t.co/kZMcGoOOl
1/ #Cefiderocol Is mainly a drug vs. aerobic GNR! - NO activity vs. Gram positives and anaerobes! (Answer to poll - NOT active vs. B fragilis) Zhanel, G.G. et al. Drugs (2019) 79: 271. https://t.co/kZMcGoOOlt
FDA approves new antibacterial drug to treat complicated urinary tract infections as part of ongoing efforts to address antimicrobial resistance https://t.co/ElVCkacHQV cefiderocol: https://t.co/1MdiiQbYJP https://t.co/L1BHqmhMGp
@MysteriousMole1 The cefiderocol development work is well worth a read if you have a chance. They had a data readout just recently at ID week. https://t.co/YZCqVbCYHE
Cefiderocol, is siderophore cephalosporin with activity against CRE and MDR gram negative bacilli #OTILT @BWDionne @mmaleissa @G_loves_Pacman https://t.co/HfR8QhKZzV
RT @PIDSociety: .@jpogue1 — on the horizon for #antibioticresistant Pseudomonas are imipenem-relebactam and cefiderocol — https://t.co/nseU…
RT @PIDSociety: .@jpogue1 — on the horizon for #antibioticresistant Pseudomonas are imipenem-relebactam and cefiderocol — https://t.co/nseU…
RT @PIDSociety: .@jpogue1 — on the horizon for #antibioticresistant Pseudomonas are imipenem-relebactam and cefiderocol — https://t.co/nseU…
RT @PIDSociety: .@jpogue1 — on the horizon for #antibioticresistant Pseudomonas are imipenem-relebactam and cefiderocol — https://t.co/nseU…
RT @PIDSociety: .@jpogue1 — on the horizon for #antibioticresistant Pseudomonas are imipenem-relebactam and cefiderocol — https://t.co/nseU…
RT @PIDSociety: .@jpogue1 — on the horizon for #antibioticresistant Pseudomonas are imipenem-relebactam and cefiderocol — https://t.co/nseU…
.@jpogue1 — on the horizon for #antibioticresistant Pseudomonas are imipenem-relebactam and cefiderocol — https://t.co/nseUXMdwdo, https://t.co/iN2azSOYkM, https://t.co/gaN3YtqogL, https://t.co/GbpChJqbdY. #PIDSASP19 @SIDPharm
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
3)
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
Cefiderocol 👍🏻
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
Zhanel, GG, Golden, AR, Zelenitsky, S. et al. Drugs (2019) 79: 271. https://t.co/CaBxhlnRzN. https://t.co/8qrBnGksmM
RT @MediCasos: #conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https:/…
#conocimientonuevo | ¿Ya había leído sobre Cefiderococol? Cefalosporina siderofora contra bacilos gram negativos. https://t.co/dMmKOJJ3AN #medicina infecto #antibiotico
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
RT @jhorcajada: Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and…
Excellent review by Dr Zhanel about Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. - PubMed - NCBI https://t.co/slg0cK7Aur
RT @MicrobLog_me_uk: Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negat…
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli https://t.co/cjCZYpuudB @bhogal_pathogen @AntibioticLeeds
RT @A_baumannii: Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative…
RT @A_baumannii: Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative…
@CARB_X @saveantibiotics @AntibioticResis @gardp_amr @koutterson Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli https://t.co/8lacRqrtAX
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. https://t.co/vQkC8oqela
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli Review by George G. Zhanel, et al. https://t.co/DgFAoYpNUz
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. https://t.co/sfyrnxTHpf
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. https://t.co/4KDn4M9zYm https://t.co/Fjyo7lDJXY